The Predictors and Long-Term Trajectory of Poststroke Cognitive Decline
中风后认知衰退的预测因子和长期轨迹
基本信息
- 批准号:8300428
- 负责人:
- 金额:$ 15.93万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-09-01 至 2016-08-31
- 项目状态:已结题
- 来源:
- 关键词:AdultAgeAged, 80 and overAntihypertensive AgentsAreaAttenuatedBehaviorBehavioralBlack raceBlood PressureBlood VesselsCaringCholesterolChronic DiseaseClinicalClinical ServicesClinical TrialsCognitiveCohort StudiesCommunitiesDataData CollectionDementiaDemographic FactorsDevelopmentDevelopment PlansDiabetes MellitusDiseaseElderlyEnsureEnvironmentEpidemiologic StudiesEquilibriumFemaleFundingFutureGenderGeographic FactorGeographyGeriatricsGoalsGrantHealthHealth Care CostsHealth behaviorHealthcareHypertensionImpaired cognitionIndividualInterventionIntervention StudiesJunior PhysicianK-Series Research Career ProgramsKnowledgeLeadLocationLong-Term EffectsMeasurementMeasuresMedicalMentorsMethodsMexican AmericansMichiganMorbidity - disease rateNot Hispanic or LatinoOutcomeParticipantPathway interactionsPatientsPhysiciansPopulationPopulation DecreasesPrevalenceQuality of lifeRaceRecording of previous eventsRehabilitation therapyResearchResource AllocationResourcesRiskRisk FactorsRuralSamplingScientistSeriesStrokeStroke preventionSurvival RateSurvivorsTestingTimeUnited States National Institutes of HealthUniversitiesacute strokeage relatedaging populationblood pressure regulationcareer developmentcigarette smokingcognitive changecognitive functioncohortdemographicsdesigndisabilityeffective therapyepidemiology studyexperiencegeographic differencehigh riskimprovedmedication compliancemiddle agemortalitymultidisciplinarypopulation basedpost strokepreventprogramsprospectiveracial differenceresidenceskillssuccesstreatment adherence
项目摘要
DESCRIPTION (provided by applicant): With population aging and improved stroke survival, the rates of post stroke cognitive decline (PSCD) are increasing. PSCD is associated with adverse health outcomes, increased health costs, and poorer quality of life. There is significant variability in which stroke patients develop PSCD. Many factors likely drive this variability, including age at stroke, time from stroke onset, stroke features, socio-demographics, geography, health conditions, behaviors and medical care factors. Yet, PSCD remains poorly understood. The long-term goal of this career development award is to promote the candidate's development into a leader and independently funded physician-scientist in PSCD among older adults. The aims of this project are: 1) To determine the impact of stroke on cognitive function, both in the short-term and the long-term; 2) To determine the socio-demographic, geographic, medical, and behavioral predictors of PSCD; 3) To assess whether blood pressure or anti-hypertensive medication adherence are associated with cognitive function in stroke survivors using primary and secondary data. This project will combine data from 2 leading prospective stroke cohort studies in the US: 1) a large, geographically dispersed, race- and gender-balanced cohort of middle-aged and older adults being followed for stroke and cognitive decline and with premorbid and post stroke cognitive assessments, and 2) a population-based stroke surveillance project in a bi-ethnic community with immediate post stroke cognitive assessments. Both cohort studies have cognitive measures sensitive to PSCD and data on stroke features. This research will generate knowledge by better identifying potential mechanisms of PSCD and will assist in planning interventions to improve the care and prevention of stroke and PSCD. This research ultimately will lead to greater understanding of PSCD, better treatments, and better outcomes in older people. The candidate, Dr. Deborah Levine, who will focus her research on the growing population of stroke survivors, will pursue a mentored research plan designed to enhance her skills in the methods needed to study PSCD. A detailed career development plan will promote the candidate's development of expertise in four areas: 1) the analysis and conduct of longitudinal epidemiologic studies of older adults; 2) the measurement of cognitive outcomes; 3) patient treatment adherence and chronic illness interventions; and 4) geriatrics and stroke care. The career development plan consists of a multidisciplinary team of experienced mentors and advisors who will oversee a range of formal coursework and practical experiences in these areas to ensure the candidate's future success. Exceptional resources of a top university and a mentoring team with proven success in developing junior physician-scientists in these topic areas makes the University of Michigan an ideal environment for this project.
PUBLIC HEALTH RELEVANCE: One in three individuals will experience dementia, a stroke, or both during their lifetime. A key question for this new century is: In this era of population aging
and improved stroke survival, how can cognitive disability from stroke be reduced or delayed? To begin to confront this problem, we will establish a research program to study the epidemiology of post stroke cognitive decline and to identify risk factors that may be targets for future intervention studies. Reducing post stroke cognitive decline will be important to decrease the risk and population burden of stroke and dementia. Information from this study will better identify potential mechanisms of post stroke cognitive decline and may assist in planning interventions to reduce or prevent post stroke cognitive decline in older adults.
描述(由申请人提供):随着人口老龄化和中风生存率的提高,中风后认知能力下降(PSCD)的发生率正在增加。 PSCD 与不良健康结果、增加的健康成本和较差的生活质量有关。中风患者发生 PSCD 的情况存在显着差异。许多因素可能导致这种变异性,包括中风年龄、中风发病时间、中风特征、社会人口统计、地理、健康状况、行为和医疗保健因素。然而,人们对 PSCD 的了解仍然知之甚少。该职业发展奖的长期目标是促进候选人发展成为老年人 PSCD 领域的领导者和独立资助的医师科学家。该项目的目标是: 1) 确定中风对认知功能的短期和长期影响; 2) 确定 PSCD 的社会人口、地理、医学和行为预测因素; 3) 使用主要和次要数据评估血压或抗高血压药物依从性是否与中风幸存者的认知功能相关。该项目将结合美国两项领先的前瞻性中风队列研究的数据:1)对一个大型、地理分散、种族和性别平衡的中老年人队列进行跟踪,了解中风和认知能力下降情况以及发病前和发病后的情况。中风认知评估,以及 2) 在双种族社区中开展基于人群的中风监测项目,并立即进行中风后认知评估。这两项队列研究都有对 PSCD 敏感的认知测量和中风特征数据。这项研究将通过更好地识别 PSCD 的潜在机制来产生知识,并将有助于规划干预措施,以改善中风和 PSCD 的护理和预防。这项研究最终将加深对 PSCD 的了解,为老年人提供更好的治疗和更好的结果。 候选人黛博拉·莱文 (Deborah Levine) 博士将把研究重点放在不断增长的中风幸存者群体上,她将实施一项指导性研究计划,旨在提高她研究 PSCD 所需方法的技能。详细的职业发展计划将促进候选人在四个领域的专业知识发展:1)分析和进行老年人的纵向流行病学研究; 2)认知结果的测量; 3)患者治疗依从性和慢性病干预措施; 4) 老年病学和中风护理。职业发展计划由经验丰富的导师和顾问组成的多学科团队组成,他们将监督这些领域的一系列正式课程和实践经验,以确保候选人未来的成功。顶尖大学的卓越资源和在这些主题领域培养初级医师科学家方面取得成功的指导团队使密歇根大学成为该项目的理想环境。
公共卫生相关性:三分之一的人在一生中会患上痴呆症、中风或两者兼而有之。新世纪的一个关键问题是:在人口老龄化的时代
并提高中风生存率,如何减少或延迟中风导致的认知障碍?为了开始面对这个问题,我们将建立一个研究计划来研究中风后认知能力下降的流行病学,并确定可能成为未来干预研究目标的危险因素。减少中风后认知能力下降对于降低中风和痴呆的风险和人口负担非常重要。这项研究的信息将更好地确定中风后认知能力下降的潜在机制,并可能有助于规划干预措施,以减少或预防老年人中风后认知能力下降。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Deborah Levine其他文献
Deborah Levine的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Deborah Levine', 18)}}的其他基金
The Effect of Vascular Risk Factors on Risk of Alzheimer's Disease and Related Dementias after Stroke (STROKE COG)
血管危险因素对中风后阿尔茨海默病和相关痴呆症 (STROKE COG) 风险的影响
- 批准号:
10030919 - 财政年份:2020
- 资助金额:
$ 15.93万 - 项目类别:
The Effect of Lower Blood Pressure over the Life Course on Late-life Cognition in Blacks, Hispanics, and Whites (BP-COG)
一生中较低血压对黑人、西班牙裔和白人晚年认知的影响 (BP-COG)
- 批准号:
9367047 - 财政年份:2017
- 资助金额:
$ 15.93万 - 项目类别:
The Effect of Lower Blood Pressure over the Life Course on Late-life Cognition in Blacks, Hispanics, and Whites (BP-COG)
一生中较低血压对黑人、西班牙裔和白人晚年认知的影响 (BP-COG)
- 批准号:
10198048 - 财政年份:2017
- 资助金额:
$ 15.93万 - 项目类别:
Decision Making for Cardiovascular Therapy in Adults with Mild Cognitive Impairment
轻度认知障碍成人心血管治疗的决策
- 批准号:
9519775 - 财政年份:2016
- 资助金额:
$ 15.93万 - 项目类别:
Decision Making for Cardiovascular Therapy in Adults with Mild Cognitive Impairment
轻度认知障碍成人心血管治疗的决策
- 批准号:
9926790 - 财政年份:2016
- 资助金额:
$ 15.93万 - 项目类别:
Decision Making for Cardiovascular Therapy in Adults with Mild Cognitive Impairment
轻度认知障碍成人心血管治疗的决策
- 批准号:
9346592 - 财政年份:2016
- 资助金额:
$ 15.93万 - 项目类别:
The Predictors and Long-Term Trajectory of Poststroke Cognitive Decline
中风后认知衰退的预测因子和长期轨迹
- 批准号:
8721822 - 财政年份:2012
- 资助金额:
$ 15.93万 - 项目类别:
The Predictors and Long-Term Trajectory of Poststroke Cognitive Decline
中风后认知衰退的预测因素和长期轨迹
- 批准号:
8850769 - 财政年份:2012
- 资助金额:
$ 15.93万 - 项目类别:
The Predictors and Long-Term Trajectory of Poststroke Cognitive Decline
中风后认知衰退的预测因子和长期轨迹
- 批准号:
8531124 - 财政年份:2012
- 资助金额:
$ 15.93万 - 项目类别:
相似国自然基金
HTRA1介导CTRP5调控脂代谢通路在年龄相关性黄斑变性中的致病机制研究
- 批准号:82301231
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
PLAAT3降低介导线粒体降解异常在年龄相关性白内障发病中的作用及机制
- 批准号:82301190
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
跨尺度年龄自适应儿童头部模型构建与弥漫性轴索损伤行为及表征研究
- 批准号:52375281
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
ALKBH5通过SHP-1调控视网膜色素上皮细胞铁死亡在年龄相关性黄斑变性中的作用机制研究
- 批准号:82301213
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
视网膜色素上皮细胞中NAD+水解酶SARM1调控自噬溶酶体途径参与年龄相关性黄斑变性的机制研究
- 批准号:82301214
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Vision Impairment in the National Health and Aging Trends Study: Epidemiology, Social Determinants of Health, and Adverse Late Life Outcomes
国家健康和老龄化趋势研究中的视力障碍:流行病学、健康的社会决定因素和不良的晚年结局
- 批准号:
10730418 - 财政年份:2023
- 资助金额:
$ 15.93万 - 项目类别:
Driving the Progeny of Olfactory HBC Stem Cells toward Neuronal Differentiation
驱动嗅觉 HBC 干细胞后代向神经元分化
- 批准号:
10527167 - 财政年份:2022
- 资助金额:
$ 15.93万 - 项目类别:
Driving the Progeny of Olfactory HBC Stem Cells toward Neuronal Differentiation
驱动嗅觉 HBC 干细胞后代向神经元分化
- 批准号:
10642890 - 财政年份:2022
- 资助金额:
$ 15.93万 - 项目类别:
Prognostic Implications of Home-Based Blood Pressure Monitoring in Older Adults
老年人家庭血压监测的预后意义
- 批准号:
10631185 - 财政年份:2021
- 资助金额:
$ 15.93万 - 项目类别:
Immunogenicity of recombinant zoster vaccine in Rheumatoid arthritis patients
重组带状疱疹疫苗对类风湿关节炎患者的免疫原性
- 批准号:
10663064 - 财政年份:2021
- 资助金额:
$ 15.93万 - 项目类别: